Agenus (AGEN) Misses Q3 EPS by 17c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/15/2026

1. DPZ
2. NVDA
3. DRS
4. GS
5. BAC
6. ORCL
7. AVAV
8. ACI
9. UNH
10. SPY

Go back to Agenus (AGEN) Misses Q3 EPS by 17c

Agenus Reports Third Quarter Financial Results and Recent Highlights

October 27, 2016 8:50 AM EDT

LEXINGTON, Mass., Oct. 27, 2016 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company developing antibodies, including checkpoint inhibitors and other checkpoint modulators and cancer vaccines, today provided an update on its progress and reported financial results for the third quarter ended September 30, 2016.

"In the third quarter we advanced our pre-clinical and clinical programs and focused our efforts on our product development plans with an intent to commercialize Agenus' first generation of I-O products in... More